Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?

Authors

Jose de Leon, University of KentuckyFollow

Document Type

Article

Publication Date

7-2015

Notes/Citation Information

Published in Journal of the American Academy of Child & Adolescent Psychiatry, v. 54, no. 7, p. 532–534.

© 2015 American Academy of Child and Adolescent Psychiatry

This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/

Digital Object Identifier (DOI)

http://dx.doi.org/10.1016/j.jaac.2015.04.003

Repository Citation

de Leon, Jose, "Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?" (2015). Psychiatry Faculty Publications. 32.
https://uknowledge.uky.edu/psychiatry_facpub/32